Showing results (141-150 of 155) with videos related to
Sort By:
Pageof 16
Rheumatology (Oxford, England)|January 20, 2026
Validating treat-to-target endpoints in childhood lupus: data-driven sensitivity analyses from the UK JSLE cohort studyChandni Sarker, Andrea L Jorgensen, Kukatharmini Tharmaratnam, et al.Rheumatology (Oxford, England)|March 10, 2021
Limited sensitivity and specificity of the ACR/EULAR-2019 classification criteria for SLE in JSLE?-observations from the UK JSLE Cohort StudyEve M D Smith, Sajida Rasul, Coziana Ciurtin, et al.Rheumatology (Oxford, England)|February 6, 2025
Validation of childhood lupus specific targets: ensuring accurate assessment of disease control in younger, lighter paediatric patientsChandni Sarker, Andrea L Jorgensen, Kukatharmini Tharmaratnam, et al.Arthritis & Rheumatology (Hoboken, N.J.)|July 18, 2019
Toward Accelerated Authorization and Access to New Medicines for Juvenile Idiopathic ArthritisLaura E Schanberg, Athimalaipet V Ramanan, Fabrizio De Benedetti, et al.American Journal of Ophthalmology|September 10, 2017
Blau Syndrome-Associated Uveitis: Preliminary Results From an International Prospective Interventional Case SeriesInge L Sarens, Ingele Casteels, Jordi Anton, et al.RMD Open|February 6, 2016
Expert consensus on dynamics of laboratory tests for diagnosis of macrophage activation syndrome complicating systemic juvenile idiopathic arthritisAngelo Ravelli, Francesca Minoia, Sergio Davì, et al.Arthritis & Rheumatology (Hoboken, N.J.)|August 29, 2015
2016 Classification Criteria for Macrophage Activation Syndrome Complicating Systemic Juvenile Idiopathic Arthritis: A European League Against Rheumatism/American College of Rheumatology/Paediatric Rheumatology International Trials Organisation Collaborative InitiativeAngelo Ravelli, Francesca Minoia, Sergio Davì, et al.Annals of the Rheumatic Diseases|February 12, 2016
2016 Classification Criteria for Macrophage Activation Syndrome Complicating Systemic Juvenile Idiopathic Arthritis: A European League Against Rheumatism/American College of Rheumatology/Paediatric Rheumatology International Trials Organisation Collaborative InitiativeAngelo Ravelli, Francesca Minoia, Sergio Davì, et al.Lancet (London, England)|June 12, 2022
Safety and immunogenicity of the ChAdOx1 nCoV-19 (AZD1222) vaccine in children aged 6-17 years: a preliminary report of COV006, a phase 2 single-blind, randomised, controlled trialGrace Li, Federica Cappuccini, Natalie G Marchevsky, et al.The Journal of Experimental Medicine|July 15, 2021
Impaired respiratory burst contributes to infections in PKCδ-deficient patientsAnna-Lena Neehus, Kunihiko Moriya, Alejandro Nieto-Patlán, et al.Pageof 16